ImmunityBio, Inc. financial statements
ImmunityBio, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 113.29M | 10-K |
| Net income | −USD 351.4M | 10-K |
| Cash and equivalents | USD 88.33M | 10-Q |
| Total debt | USD 878.12M | EODHD |
ImmunityBio, Inc. financials on 6ix · ImmunityBio, Inc. on 6ix